Icu Medical (ICUI) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Powered by 
Analysis
Icu Medical (ICUI) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 22.97% |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 20.02% |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 51.47% |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | -7.83% |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 29.05% |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 18.63% |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | - |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn | 53.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.52% |
| Mar 31, 2026 | 74.38% |
| Dec 31, 2025 | 5.17% |
| Sep 30, 2025 | 48.02% |
| Jun 30, 2025 | 88.10% |
| Mar 31, 2025 | 30.37% |
| Dec 31, 2024 | -47.30% |
| Sep 30, 2024 | -45.20% |
| Jun 30, 2024 | -35.97% |
| Mar 31, 2024 | -49.56% |
| Dec 31, 2023 | -38.49% |
| Sep 30, 2023 | -33.83% |
| Jun 30, 2023 | -36.18% |
| Mar 31, 2023 | -37.20% |
| Dec 31, 2022 | -40.15% |
| Sep 30, 2022 | -35.67% |
| Jun 30, 2022 | -32.52% |
| Mar 31, 2022 | -47.79% |
| Dec 31, 2021 | 67.61% |
| Sep 30, 2021 | 421.62% |